WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS

B02A ANTIFIBRINOLYTICS

This group comprises agents, which inhibit fibrinolytic activity.

Combinations with vitamin K, see B02B - Vitamin K and other hemostatics.

The DDDs are based on treatment of hemorrhage associated with fibrinolysis.

B02B VITAMIN K AND OTHER HEMOSTATICS

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).

Last updated: 2016-12-20